Tag Archives: Prostate cancer

Anti-androgen therapy improves survival for men with cancer recurrence after prostatectomy

Men with prostate cancer who have¬†prostate-specific antigen¬†recurrence following radical prostatectomy have improved survival with radiotherapy and a long-term course of anti androgen therapy. It is well established that a rising serum prostate-specific antigen (PSA) level is an indication of cancer … Continue reading

Posted in Presentation | Tagged , , , | Leave a comment

Increased radiation offers no survival benefit for patients with low-risk prostate cancer

Increased radiation dose was only associated with higher survival rates in men with more aggressive cancers Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, … Continue reading

Posted in Research | Tagged , , , | Leave a comment

New screening method for prostate cancer recurrence

The American Cancer Society estimated that 220,800 new cases of prostate cancer will be diagnosed in the United States in 2015. Approximately 27,540 men will die of the disease, accounting for 5 percent of all cancer deaths. A common treatment … Continue reading

Posted in Research | Tagged , , | Leave a comment

Statin drugs can delay prostate cancer progression in patients

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn’t take statins, a clinical trial led by Dana-Farber … Continue reading

Posted in Research | Tagged , , | Leave a comment

Detecting cancer cells in blood can give an early warning of treatment failure

A blood test that measures the number of cells shed from prostate tumours into the bloodstream can act as an early warning sign that treatment is not working, a major new study shows.¬†Researchers showed that measuring the numbers of circulating … Continue reading

Posted in Research | Tagged , , | Leave a comment

HIV drug blocks bone metastases in prostate cancer

The receptor CCR5, targeted by HIV drugs, is also key in driving prostate cancer metastases, suggesting that blocking this molecule could slow prostate cancer spread. Although prostate cancer can be successfully treated in many men, when the disease metastasizes to … Continue reading

Posted in Research | Tagged , , | Leave a comment

Prostate cancer in younger men — More frequent and aggressive?

Early onset prostate cancer is a newly identified, more aggressive subtype often linked to genetic mutations. The number of younger men diagnosed with prostate cancer has increased nearly 6-fold in the last 20 years, and the disease is more likely … Continue reading

Posted in Review | Tagged , , | 1 Comment